Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03750903 · ClinicalTrials.gov registry record · NA

Effect of Aging on Cortical Excitability and Motor Learning

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03750903: Completed NA study, sponsored by VA Office of Research and Development.

NCT03750903 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03750903, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The objective of the current proposal is to identify 1) how aging-related changes in GABAergic cortical inhibition affect motor performance, and 2) how aerobic exercise may improve inhibitory function and facilitate motor learning.

Primary Outcome

Measuring changes in dynamic magnetic resonance spectroscopy of primary motor cortex during motor learning.

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Stretching and Balance Training

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-03-04
Est. Completion 2024-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03750903 record still lists

NCT03750903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Aerobic Exercise is the first listed.

NCT03750903 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03750903 about?

NCT03750903 is a clinical study titled "Effect of Aging on Cortical Excitability and Motor Learning". The objective of the current proposal is to identify 1) how aging-related changes in GABAergic cortical inhibition affect motor performance, and 2) how aerobic exercise may improve inhibitory function and facilitate motor learning.

What is the current status of trial NCT03750903?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-03-04. Estimated completion is 2024-09-30.

What interventions are being tested in trial NCT03750903?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Stretching and Balance Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03750903?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03750903's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03750903, the US trial registry maintained by the National Library of Medicine. NCT03750903 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.